Ying Wei Lin
Impact in
-
- NF-κB Signaling Pathways
-
- Immune Response and Inflammation
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
Papers in
-
- NF-κB Signaling Pathways 3
- Co-authors
- Yoshihiro WakazonoMasaru KubotaKatsuji KuwakadoHaruyo HirotaKousaku MatsubaraRyuta NishikomoriMasahiko KawaiToshio Heike
In The Last Decade
Ying Wei Lin
14 papers receiving 378 citations
Peers
Comparison fields: 5 of 78
- Cancer Research 128
- Immunology 116
- Toxicology 16
- Molecular Biology 212
- Oncology 74
Countries citing papers authored by Ying Wei Lin
This map shows the geographic impact of Ying Wei Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Wei Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Wei Lin more than expected).
Fields of papers citing papers by Ying Wei Lin
This network shows the impact of papers produced by Ying Wei Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Wei Lin. The network helps show where Ying Wei Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Ying Wei Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 0 | |
| 2 | 2011 | 11 | |
| 3 | Stable transfection of estrogen receptor-alpha suppresses expression of cyclooxygenase-2 and vascular endothelial growth factor-C in MDA-MB-231 breast cancer cells. | 2010 | 1 |
| 4 | 1998 | 21 | |
| 5 | Prospective study of mutant frequencies at the hprt and T-cell receptor gene loci in pediatric cancer patients during chemotherapy. | 1998 | 8 |
| 6 | 1997 | 6 | |
| 7 | 1997 | 1 | |
| 8 | NADH dehydrogenase deficiency in an apoptosis-resistant mutant isolated from a human HL-60 leukemia cell line. | 1997 | 12 |
| 9 | 1996 | 8 | |
| 10 | 1995 | 10 | |
| 11 | 1995 | 33 | |
| 12 | 1994 | 39 | |
| 13 | 1994 | 14 | |
| 14 | 1994 | 26 | |
| 15 | 1994 | 198 |
About Ying Wei Lin
Ying Wei Lin is a scholar working on Toxicology, Cancer Research, Hematology, Genetics and Immunology, having authored 15 papers that have together received 388 indexed citations. Recurring topics across this work include DNA and Nucleic Acid Chemistry (3 papers), Acute Lymphoblastic Leukemia research (3 papers), RNA Interference and Gene Delivery (3 papers), NF-κB Signaling Pathways (3 papers), Acute Myeloid Leukemia Research (2 papers), Genomics, phytochemicals, and oxidative stress (2 papers), Estrogen and related hormone effects (2 papers) and DNA Repair Mechanisms (2 papers). The work is most often cited by research in Cancer Research (128 citations), Immunology (116 citations), Toxicology (16 citations), Molecular Biology (212 citations) and Oncology (74 citations). Ying Wei Lin has collaborated with scholars based in Japan and China. Frequent co-authors include Yoshihiro Wakazono, Masaru Kubota, Katsuji Kuwakado, Haruyo Hirota, Kousaku Matsubara, Ryuta Nishikomori, Masahiko Kawai, Toshio Heike, Yuichi Akiyama and Ikuya Usami. Their work appears in journals such as European Journal Of Haematology, Biochemical Pharmacology, Mutation Research/DNA Repair, Oncology Reports and FEBS Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.